{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00460538",
      "orgStudyIdInfo": {
        "id": "MIL-002"
      },
      "organization": {
        "fullName": "Milsing d.o.o.",
        "class": "OTHER"
      },
      "briefTitle": "Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms",
      "officialTitle": "Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms"
    },
    "statusModule": {
      "statusVerifiedDate": "2010-03",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2007-04"
      },
      "primaryCompletionDateStruct": {
        "date": "2007-10",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2007-11",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2007-04-13",
      "studyFirstSubmitQcDate": "2007-04-13",
      "studyFirstPostDateStruct": {
        "date": "2007-04-16",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2010-04-02",
      "lastUpdatePostDateStruct": {
        "date": "2010-04-05",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "oldNameTitle": "Neven Tudoric MD PhD",
        "oldOrganization": "Dubrava University Hospital, Zagreb, Croatia"
      },
      "leadSponsor": {
        "name": "Milsing d.o.o.",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.",
      "detailedDescription": "Patients allergic to the specific pollen are divided into two groups randomly. One group is being administered Lectranal and the other group is being administered placebo during the period of 6 weeks in season of the pollen. Methods used for evaluation are: SARS questionnaire(seasonal allergic rhinitis symptoms), Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire) skin Prick test, specific IgE and IgG, eosinophilia in nasal secretion. Methods used for follow up safety include side effects report, physical examination and vital signs."
    },
    "conditionsModule": {
      "conditions": [
        "Seasonal Allergic Rhinitis"
      ],
      "keywords": [
        "Seasonal allergic rhinitis",
        "lectranal",
        "allergy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "DOUBLE",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 48,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "2",
          "type": "PLACEBO_COMPARATOR",
          "interventionNames": [
            "Dietary Supplement: placebo"
          ]
        },
        {
          "label": "1",
          "type": "ACTIVE_COMPARATOR",
          "interventionNames": [
            "Dietary Supplement: Lectranal"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DIETARY_SUPPLEMENT",
          "name": "Lectranal",
          "description": "Dosage form: capsule\n\n1: Dosage: 2 capsule Frequency and duration: 2 times daily over the 6 weeks",
          "armGroupLabels": [
            "1"
          ]
        },
        {
          "type": "DIETARY_SUPPLEMENT",
          "name": "placebo",
          "description": "Dosage form: capsule 2: Dosage: 2 capsules Frequency and duration: 2 times daily over the 6 weeks",
          "armGroupLabels": [
            "2"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "changes in SARS (seasonal allergic rhinitis symptoms)",
          "timeFrame": "6 weeks"
        },
        {
          "measure": "changes in Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire)",
          "timeFrame": "6 weeks"
        },
        {
          "measure": "changes in specific IgE",
          "timeFrame": "6 weeks"
        },
        {
          "measure": "changes in specific IgG",
          "timeFrame": "6 weeks"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Prick test change",
          "timeFrame": "6 weeks"
        },
        {
          "measure": "change in eosinophilia in nasal secretion",
          "timeFrame": "6 weeks"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* history of seasonal allergic rhinitis symptoms to pollen\n* positive skin prick test to pollen\n* negative history of seasonal allergic asthma\n* male or female older than 18\n* female participants must use appropriate contraception\n* able to comply to study procedures\n\nExclusion Criteria:\n\n* pregnancy\n* alcohol or drug abuse\n* subject receiving antihistamines , immunotherapy or on hyposensibilisation",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Neven Tudoric, MD PhD",
          "affiliation": "Dubrava University Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Dubrava University Hospital",
          "city": "Zagreb",
          "zip": "10000",
          "country": "Croatia",
          "geoPoint": {
            "lat": 45.81444,
            "lon": 15.97798
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "19504468",
          "type": "RESULT",
          "citation": "Matkovic Z, Zivkovic V, Korica M, Plavec D, Pecanic S, Tudoric N. Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis. Phytother Res. 2010 Feb;24(2):175-81. doi: 10.1002/ptr.2877."
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006255",
          "term": "Rhinitis, Allergic, Seasonal"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        }
      ],
      "ancestors": [
        {
          "id": "D065631",
          "term": "Rhinitis, Allergic"
        },
        {
          "id": "D012220",
          "term": "Rhinitis"
        },
        {
          "id": "D009668",
          "term": "Nose Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D010038",
          "term": "Otorhinolaryngologic Diseases"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": false
}